Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
78 /100
CRITICAL RISK
Score updated Oct 13, 2026

INDP — Indaptus Therapeutics, Inc. Dilution Risk Tracker

Track INDP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track INDP — Get alerts when the score changes →

As of October 13, 2026, Indaptus Therapeutics, Inc. (INDP) has a DilutionWatch DilutionScore of 78/100, rated CRITICAL dilution risk. Indaptus Therapeutics, Inc. has a market capitalization of $330.44M, 133.24M shares outstanding, 1 institutional holders tracked. Stored dilution-related fields include 175.4K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
65
📊 Float Risk
100
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 20%
🔄 Reverse Split model est. 25%
• 52-week low $0.92 has breached $1
• 7 months cash with weak price
💰 Capital Raise model 15%
• Under 12 months cash (7mo)
📉 Score Deterioration model 15%
• Score already CRITICAL (78/100) — events likely imminent
🔔 Track INDP — Get forecast alerts →

Market Data

Market Cap$330.44M
Shares Outstanding133.24M
Float3.24M
Cash$11.55M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore78/100DilutionWatch score record
Shares Outstanding133.24MVerified float table or market cache
Public Float3.24MVerified float table or market cache
Market Cap$330.44MMarket data cache
Cash Runway6.6 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants175.4KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 3 4, 4 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 100.0% shares (2026Q1 vs prior)
1 institutional holders · 2 shares
#1 DANSKE BANK A/S 2 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest822.2K
Days to Cover1.0
% of Float25.4%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-13
xbrl XBRL CONVERTIBLE 2026-03-17
3 FORM3 2026-04-20
3 FORM3 2026-04-02
3 FORM3 2026-04-02
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual INDP Dilution Snapshot

Indaptus Therapeutics, Inc. (INDP) has a DilutionScore of 78/100, rated Critical dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

INDP's DilutionScore is currently 78/100 (Critical risk), with 6 score changes tracked over 89 days. The score improved from 77/100 (Critical risk).

Period Score Risk Level Duration
Oct 05 – Oct 13, 202678/100CRITICAL9 days
Oct 01 – Oct 04, 202677/100CRITICAL4 days
Sep 03 – Sep 30, 202678/100CRITICAL28 days
Aug 31 – Sep 02, 202666/100HIGH3 days
Aug 22 – Aug 30, 202678/100CRITICAL9 days
Aug 14 – Aug 21, 202694/100CRITICAL7 days
Jul 16 – Aug 13, 202684/100CRITICAL29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track INDP Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment INDP files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking INDP — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for INDP
INDP FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.